Drug-Drug Interactions With Paxlovid and Select CV Medications

Jun 24, 2022   |  Nicole Martin Bhave, MD, FACC; Tyler J. Gluckman, MD, FACC; Barbara S. Wiggins, PharmD, FACC
Font Size
A
A
A

The following table includes cardiovascular medications for which potential drug-drug interactions with nirmatrelvir/ritonavir (paxlovid) interactions exist. If a drug is not listed, one cannot assume that it can be safely coadministered with nirmatrelvir/ritonavir. Updates to the table will be made as further data emerge.

Click here to download.



Clinical Topics: COVID-19 Hub

Keywords: COVID-19, SARS-CoV-2, Pandemics, Ritonavir, Drug Interactions


< Back to Listings